EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Applying to The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center · Torrance, California
Answer a few short questions to share with the research team.